Cargando…

Outcome for Patients with Triple-Negative Breast Cancer Is Not Dependent on Race/Ethnicity

Introduction. Triple negative breast cancer (TNBC) is biologically aggressive and is associated with a worse prognosis. To understand the impact of race/ethnicity on outcome for patients with TNBC, confounding factors such as socioeconomic status (SES) need to be controlled. We examined the impact o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Quyen D., Henderson, Amanda E., Ampil, Fred, Li, Benjamin D. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356882/ https://www.ncbi.nlm.nih.gov/pubmed/22645687 http://dx.doi.org/10.1155/2012/764570

Ejemplares similares

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer
por: Parise, Carol, et al.
Publicado: (2018)

Class, race and ethnicity and information avoidance among cancer survivors
por: McCloud, R F, et al.
Publicado: (2013)

Does Race Affect Outcomes in Triple Negative Breast Cancer?
por: Sachdev, Jasgit C., et al.
Publicado: (2010)

PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC)
por: Ghosh, Joydeep, et al.
Publicado: (2021)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer
por: Prat, A, et al.
Publicado: (2014)

Axillary lymph node micrometastases decrease triple-negative early breast cancer survival
por: Houvenaeghel, G, et al.
Publicado: (2016)

Long-term survival outcomes of triple-receptor negative breast cancer survivors who are disease free at 5 years and relationship with low hormone receptor positivity
por: Reddy, S M, et al.
Publicado: (2018)

Race, Ethnicity, and 60-Day Outcomes After Hospitalization With COVID-19
por: Robinson-Lane, Sheria G., et al.
Publicado: (2021)

Somatic copy number changes in DPYD are associated with lower risk of recurrence in triple-negative breast cancers
por: Gross, E, et al.
Publicado: (2013)

Racial and Ethnic Inequality in Survival Outcomes of Women With Triple Negative Breast Cancer
por: Makhani, Sarah S, et al.
Publicado: (2022)

Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer
por: Hiller, David J., et al.
Publicado: (2012)

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen
por: Giacchetti, S, et al.
Publicado: (2014)

Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes
por: Zajac, Kelsee K., et al.
Publicado: (2023)

Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
por: Niwińska, Anna, et al.
Publicado: (2011)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Horse–, training– and race–level risk factors for palmar/plantar osteochondral disease in the racing Thoroughbred
por: Pinchbeck, G L, et al.
Publicado: (2013)

Racial/Ethnic Patterns in Prostate Cancer Outcomes in an Active Surveillance Cohort
por: Cullen, Jennifer, et al.
Publicado: (2011)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study
por: Isenberg, David, et al.
Publicado: (2010)

Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
por: Vihervuori, H., et al.
Publicado: (2022)

A comparison of the molecular subtypes of triple-negative breast cancer among non-Asian and Taiwanese women
por: Tseng, Ling-Ming, et al.
Publicado: (2017)

Prospective evaluation of radiation‐induced skin toxicity in a race/ethnically diverse breast cancer population
por: Wright, Jean L., et al.
Publicado: (2016)

Female Body Mass Index and its Relationship With Triple Negative Breast Cancer and Ethnicity
por: Tariq, Khurram Bilal, et al.
Publicado: (2013)

Triple Negative Breast Cancer Profile, from Gene to microRNA, in Relation to Ethnicity
por: Gupta, Ishita, et al.
Publicado: (2019)

Future of Triple Negative Breast Cancer: Can Immunotherapy Treat This Deadly Subtype of Breast Cancer?
por: Salimi, Mona
Publicado: (2018)

Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
por: O’Shaughnessy, Joyce, et al.
Publicado: (2022)

Poor survival outcomes in HER2-positive breast cancer patients with low-grade, node-negative tumours
por: Tovey, S M, et al.
Publicado: (2009)

Influenza Vaccination Uptake Trends by Age, Race, and Ethnicity in the United States Between 2017 and 2020
por: Greiner, Benjamin, et al.
Publicado: (2022)

The influence of race/ethnicity and place of service on breast reconstruction for Medicare beneficiaries with mastectomy
por: Onega, Tracy, et al.
Publicado: (2014)

The General Surgery Residency Experience: A Multicenter Study of Differences in Wellbeing by Race/Ethnicity
por: Greenberg, Anya L., et al.
Publicado: (2022)

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
por: Thakkar, A., et al.
Publicado: (2016)

Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy
por: Castaneda, Carlos A, et al.
Publicado: (2016)

Opportunities for improving triple‐negative breast cancer outcomes: results of a population‐based study
por: Rapiti, Elisabetta, et al.
Publicado: (2017)

Ethnic differences in prostate cancer
por: Kheirandish, P, et al.
Publicado: (2011)

Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
por: Cho, Soo Young
Publicado: (2019)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_uh3k9mjmoceigddc94v5v8p177